BerGenBio
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
BGBIO | OL
Overview
Corporate Details
- ISIN(s):
- NO0012921180 (+2 more)
- LEI:
- 213800TYYFXKYF3V2A23
- Country:
- Norway
- Address:
- MØLLENDALSBAKKEN 9, 5009 BERGEN
- Website:
- https://www.bergenbio.com/
- Sector:
- Manufacturing
Description
BerGenBio was a clinical-stage biopharmaceutical company focused on developing first-in-class selective AXL kinase inhibitors. The company's therapeutic candidates targeted AXL as a potential cornerstone of therapy for aggressive, advanced, and treatment-resistant cancers. In October 2025, BerGenBio completed a merger with Oncoinvent ASA, and the combined entity was renamed Oncoinvent.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-04-02 08:53 |
BerGenBio extends Phase II trial with bemcentinib and KEYTRUDA® in NSCLC to inc…
|
English | 7.8 KB | ||
| 2019-04-02 05:00 |
BerGenBio: Preclinical data presented at AACR reinforces bemcentinib's potentia…
|
English | 7.2 KB | ||
| 2019-04-01 10:01 |
BerGenBio: Bemcentinib in combination with low-dose chemotherapy achieves effic…
|
English | 9.2 KB | ||
| 2019-03-13 23:58 |
BerGenBio ASA ("BerGenBio" or "the Company") announces key appointments to exec…
|
English | 5.5 KB | ||
| 2019-03-13 10:45 |
BerGenBio ASA: Annual general meeting
|
Norwegian | 167.7 KB | ||
| 2019-03-13 10:45 |
BerGenBio ASA: Annual general meeting
|
English | 1.6 KB | ||
| 2019-02-28 20:28 |
BerGenBio ASA: Arbitration with Rigel Pharmaceuticals, Inc resolved
|
English | 3.3 KB | ||
| 2019-02-20 15:35 |
BerGenBio ASA (BGBIO): Notice of annual general meeting
|
English | 189.7 KB | ||
| 2019-02-20 15:35 |
BerGenBio ASA (BGBIO): Notice of annual general meeting
|
English | 104.4 KB | ||
| 2019-02-20 15:35 |
BerGenBio ASA (BGBIO): Notice of annual general meeting
|
English | 1.1 KB | ||
| 2019-02-20 15:30 |
BerGenBio ASA publishes Annual Report for 2018
|
Norwegian | 11.0 MB | ||
| 2019-02-20 15:30 |
BerGenBio ASA publishes Annual Report for 2018
|
Norwegian | 45.1 KB | ||
| 2019-02-20 15:30 |
BerGenBio ASA publishes Annual Report for 2018
|
English | 2.8 KB | ||
| 2019-02-19 12:45 |
BerGenBio ASA: Primary Insider notification
|
English | 804 bytes | ||
| 2019-02-18 11:11 |
BerGenBio ASA: Share capital increase
|
English | 1.9 KB |
Automate Your Workflow. Get a real-time feed of all BerGenBio filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BerGenBio
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BerGenBio via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
